Chromatin Inc. and Bayer CropScience announced today that they have entered into a technological alliance and license agreement to use Chromatin’s proprietary mini-chromosome technology for crop improvement.
Chromatin has developed a novel approach to gene stacking, using plant DNA to deliver several genes on a single chromosome. Under the agreement, Bayer CropScience has obtained non-exclusive rights to use Chromatin’s technology to introduce Bayer’s high-value trait genes into cotton. Bayer CropScience also obtained options to expand this program to other crops. Further terms of the deal were not disclosed.
Dr. Linda Trolinder, Global Cotton R&D Manager at BioScience, a business operations unit of Bayer CropScience, welcomes the new business relationship with Chromatin: "Bayer CropScience is committed to offering top-of-the-line innovation to its customers, and Chromatin's technology enables the use of new approaches and more flexibility in research which will facilitate the speed with which we bring our products to customers.”
“Chromatin is pleased to partner with Bayer CropScience, who, with its FiberMax® brand and other technologies, is a leader in the development of new cotton varieties worldwide,” said Daphne Preuss, Chromatin’s Chief Executive Officer. “We look forward to working with Bayer CropScience to develop the next generation of crops with high-value yield and quality traits.”
MethylGPT unlocks DNA secrets for age and disease prediction